A Study to Investigate the Safety, Tolerability, and Drug Levels of BMS-986419 (Part 1) and the Effects Multiple Doses of BMS-986419 on Cardiac Repolarization (Part 2) in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BMS-986489 in Chinese Participants With Relapsed/Refractory Small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Luspatercept for Clonal Cytopenias of Uncertain Significance
- Status
- RECRUITING
- Phase
- PHASE2
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
- Status
- RECRUITING
- Phase
- PHASE2
Golcadomide and Nivolumab in Patients With Non-Hodgkin Lymphoma With Refractory Disease After Chimeric Antigen T-cell Therapy
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of Enasidenib in People With T-Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Maintenance Niraparib Plus Ipilimumab in Patients With Metastatic Pancreatic Adenocarcinoma Whose Disease Has Not Progressed on Platinum-Based Chemotherapy
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of BMS-986278 and the Effects of BMS-986278 on Cardiac Repolarization in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Outcomes of Patients With Resectable Non-Small Cell Lung Cancer Receiving Neoadjuvant Nivolumab Plus Chemotherapy in France
- Status
- COMPLETED
- Phase
- N/A
A Study of BMS-986490 With or Without Bevacizumab in Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Comprehensive Demographics and Clinical Profile of NSCLC Patients
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Tyrosine Kinase 2 (TYK2) for GA and CS
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study to Evaluate BMS-986278 in Participants With Normal Renal Function, Severe Renal Impairment, or End-Stage Renal Disease on Intermittent Hemodialysis
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate Comparative Bioavailability of BMS-986278 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
A Study on the Safety of Deucravacitinib Exposure in Pregnant Women and Their Offspring
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Randomized Phase 2 Trial of Nivolumab, Relatlimab Plus Ipilimumab vs. Nivolumab Plus Ipilimumab in First-line Advanced Renal Cell Carcinoma (RCC)
- Status
- RECRUITING
- Phase
- PHASE2
A Real-world Study to Evaluate the Effectiveness of Deucravacitinib in Adults With Plaque Psoriasis in France (RePhlect)
- Status
- RECRUITING
- Phase
- N/A